Kiran Kumar, M.D. Chief of Lymphoma and Pediatrics Radiation Oncology Services; Program Director, Medical Residency Associate Professor School Medical School Department Radiation Oncology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Education Medical School University of Chicago Pritzker School of Medicine (2013) Internship Presence Resurrection Medical Center (2014), Transitional Year Residency Stanford University Medical Center (2018), Radiation Oncology Other Post Graduate Training University of California - Berkeley (2018) Graduate School University of California - Berkeley (2018) Publications Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma Chou KN, Park DJ, Hori YS, Persad AR, Chuang C, Emrish SC, Ustrzynski L, Tayag A, Kumar K, Usoz M, Mendoza M, Rahimy E, Pollom E, Soltys SG, Lai SW, Chang SD Clinical lung cancer 2024 ACR–ARS Practice Parameter for the Performance of Total Body Irradiation Reilly M, Dandapani SV, Kumar KA, Constine L, Fogh SE, Roberts KB, Small W, Schechter NR American Journal of Clinical Oncology: Cancer Clinical Trials 2023 May 46 185-192 Serious Illness Communication Training Among Radiation Oncology Residents Christensen M, Kumar KA, Wang WS, Dharmarajan KV, Chang Z, McStay CK, Barina A, Siropaides C Practical Radiation Oncology 2023 May 13 e220-e229 Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go? Patel AM, West L, Atluri PS, Yi SF, Rizvi SM, Geethakumari PR, Awan FT, Chen W, Shah JL, Desai NB, Goff HW, Kumar KA Practical Radiation Oncology 2023 Mar 13 e192-e199 Artificial Intelligence–Empowered Radiation Oncology Residency Education Kwon YS, Dohopolski M, Morgan H, Garant A, Sher D, Rahimi A, Sanford NN, Vo D, Albuquerque K, Kumar K, Timmerman R, Jiang SB Practical Radiation Oncology 2023 Jan 13 8-10 A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W American journal of clinical pathology 2022 Sep 158 338-344 Primary central nervous system lymphoma: A real-world comparison of therapy access and outcomes by hospital setting Patel AM, Ali O, Kainthla R, Rizvi SM, Awan FT, Patel T, Pan E, Maher E, Desai NB, Timmerman R, Kumar KA, Ramakrishnan Geethakumari P Neuro-Oncology Practice 2022 May 9 183-192 T-Cell Lymphomas, Version 2.2022 Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H JNCCN Journal of the National Comprehensive Cancer Network 2022 Mar 20 285-308 Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman R, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel PA, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds Jr. RR, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X Transplantation and Cellular Therapy 2022 Feb 28 113.e1-113.e8 Fundamentals of radiation oncology for treatment of vertebral metastases Gottumukkala S, Srivastava U, Brocklehurst S, Mendel JT, Kumar K, Yu FF, Agarwal A, Shah BR, Vira S, Raj KM Radiographics 2021 Nov 41 2136-2156 Results 1-10 of 24 1 2 3 Next Last